With medications for HIV, Hepatitis and Osteoporosis, our goal is to expand our presence globally via strategic partnerships and alliances.
Therefore, we count on our highly qualified structure to meet the strictest worldwide regulatory criteria.
To support our internationalization strategy, we have an ongoing certification plan in the regulatory agencies, such as: WHO, EMA, Health Canada and FDA.
Additionally, another important pillar for Blanver is to bring strategic new products to our portfolio, with high aggregated value, that make sense for our DNA, and that allow us to quickly enter in new and promising segments.
We are open to business opportunities – either for in-licensing or for out-licensing. Contact us for more information.